P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

Clinical trial NCT06468033 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06468033
Sponsor: PharmaEssentia
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Myelofibrosis Myeloproliferative Neoplasm

Start date: 2025-07-18
Primary completion: 2027-11-18
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.